Enovis Corp. (ENOV)
27.82
+0.15
(+0.54%)
USD |
NYSE |
Dec 11, 16:00
27.82
0.00 (0.00%)
After-Hours: 20:00
Enovis Research and Development Expense (TTM): 112.92M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Baxter International, Inc. | 518.00M |
| Integra LifeSciences Holdings Corp. | 76.44M |
| Merit Medical Systems, Inc. | 96.00M |
| Repligen Corp. | 51.77M |
| Perspective Therapeutics, Inc. | 61.22M |